201 related articles for article (PubMed ID: 31439856)
21. Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Jiang H; Courau T; Borison J; Ritchie AJ; Mayer AT; Krummel MF; Collisson EA
Gastroenterology; 2022 Feb; 162(2):590-603.e14. PubMed ID: 34627860
[TBL] [Abstract][Full Text] [Related]
22. Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.
Stromnes IM; Burrack AL; Hulbert A; Bonson P; Black C; Brockenbrough JS; Raynor JF; Spartz EJ; Pierce RH; Greenberg PD; Hingorani SR
Cancer Immunol Res; 2019 Jun; 7(6):977-989. PubMed ID: 31028033
[TBL] [Abstract][Full Text] [Related]
23. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
24. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
Vernon PJ; Loux TJ; Schapiro NE; Kang R; Muthuswamy R; Kalinski P; Tang D; Lotze MT; Zeh HJ
J Immunol; 2013 Feb; 190(3):1372-9. PubMed ID: 23269246
[TBL] [Abstract][Full Text] [Related]
25. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.
Seifert L; Werba G; Tiwari S; Giao Ly NN; Nguy S; Alothman S; Alqunaibit D; Avanzi A; Daley D; Barilla R; Tippens D; Torres-Hernandez A; Hundeyin M; Mani VR; Hajdu C; Pellicciotta I; Oh P; Du K; Miller G
Gastroenterology; 2016 Jun; 150(7):1659-1672.e5. PubMed ID: 26946344
[TBL] [Abstract][Full Text] [Related]
26. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
27. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.
Fearon DT
Cancer Immunol Res; 2014 Mar; 2(3):187-93. PubMed ID: 24778314
[TBL] [Abstract][Full Text] [Related]
28. The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Michaelis KA; Norgard MA; Zhu X; Levasseur PR; Sivagnanam S; Liudahl SM; Burfeind KG; Olson B; Pelz KR; Angeles Ramos DM; Maurer HC; Olive KP; Coussens LM; Morgan TK; Marks DL
Nat Commun; 2019 Oct; 10(1):4682. PubMed ID: 31615993
[TBL] [Abstract][Full Text] [Related]
29. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma.
Baker LA; Tuveson DA
Methods Mol Biol; 2019; 1882():117-133. PubMed ID: 30378048
[TBL] [Abstract][Full Text] [Related]
30. Macrophages and pancreatic ductal adenocarcinoma.
Habtezion A; Edderkaoui M; Pandol SJ
Cancer Lett; 2016 Oct; 381(1):211-6. PubMed ID: 26708507
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
Shibuya KC; Goel VK; Xiong W; Sham JG; Pollack SM; Leahy AM; Whiting SH; Yeh MM; Yee C; Riddell SR; Pillarisetty VG
PLoS One; 2014; 9(5):e96565. PubMed ID: 24794217
[TBL] [Abstract][Full Text] [Related]
32. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer.
Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J
Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.
Blair AB; Kim VM; Muth ST; Saung MT; Lokker N; Blouw B; Armstrong TD; Jaffee EM; Tsujikawa T; Coussens LM; He J; Burkhart RA; Wolfgang CL; Zheng L
Clin Cancer Res; 2019 Sep; 25(17):5351-5363. PubMed ID: 31186314
[TBL] [Abstract][Full Text] [Related]
34. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
Hosein AN; Huang H; Wang Z; Parmar K; Du W; Huang J; Maitra A; Olson E; Verma U; Brekken RA
JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335328
[TBL] [Abstract][Full Text] [Related]
35. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.
Yang MW; Tao LY; Jiang YS; Yang JY; Huo YM; Liu DJ; Li J; Fu XL; He R; Lin C; Liu W; Zhang JF; Hua R; Li Q; Jiang SH; Hu LP; Tian GA; Zhang XX; Niu N; Lu P; Shi J; Xiao GG; Wang LW; Xue J; Zhang ZG; Sun YW
Cancer Res; 2020 May; 80(10):1991-2003. PubMed ID: 32098780
[TBL] [Abstract][Full Text] [Related]
36. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.
Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L
Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191
[TBL] [Abstract][Full Text] [Related]
37. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
Öhlund D; Handly-Santana A; Biffi G; Elyada E; Almeida AS; Ponz-Sarvise M; Corbo V; Oni TE; Hearn SA; Lee EJ; Chio II; Hwang CI; Tiriac H; Baker LA; Engle DD; Feig C; Kultti A; Egeblad M; Fearon DT; Crawford JM; Clevers H; Park Y; Tuveson DA
J Exp Med; 2017 Mar; 214(3):579-596. PubMed ID: 28232471
[TBL] [Abstract][Full Text] [Related]
38. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer.
Mirlekar B; Michaud D; Searcy R; Greene K; Pylayeva-Gupta Y
Cancer Immunol Res; 2018 Sep; 6(9):1014-1024. PubMed ID: 29980536
[TBL] [Abstract][Full Text] [Related]
39. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F; Nicolle R; Blum Y; Cros J; Marisa L; Demetter P; Quertinmont E; Svrcek M; Elarouci N; Iovanna J; Franchimont D; Verset L; Galdon MG; Devière J; de Reyniès A; Laurent-Puig P; Van Laethem JL; Bachet JB; Maréchal R
Gastroenterology; 2018 Dec; 155(6):1999-2013.e3. PubMed ID: 30165049
[TBL] [Abstract][Full Text] [Related]
40. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer.
Raymant M; Astuti Y; Alvaro-Espinosa L; Green D; Quaranta V; Bellomo G; Glenn M; Chandran-Gorner V; Palmer DH; Halloran C; Ghaneh P; Henderson NC; Morton JP; Valiente M; Mielgo A; Schmid MC
Nat Commun; 2024 Apr; 15(1):3593. PubMed ID: 38678021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]